6.40Open6.40Pre Close0 Volume2 Open Interest22.50Strike Price0.00Turnover240.00%IV6.88%PremiumDec 20, 2024Expiry Date5.21Intrinsic Value100Multiplier5DDays to Expiry1.19Extrinsic Value100Contract SizeAmericanOptions Type-0.7688Delta0.0593Gamma2.98Leverage Ratio-0.1388Theta-0.0026Rho-2.29Eff Leverage0.0065Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet